|
|
|
|
|
 |
|
Robert Langenbach, PhD.
Robert Langenbach, Ph.D
Department of Environmental and Molecular Toxicology
The National Institute of Environmental Health Sciences
North Carolina State University
website: http://www.niehs.nih.gov/research/atniehs/labs/lmc/metabolism/index.cfm
|
|
 |
 |
 |
|
Topic:
|
 |
“The prostaglandin E2 receptor, EP2, contributes to mouse skin tumor
development by activating multiple signaling pathways” |
 |
|
|
 |
|
 |
|
When:
|
 |
Monday, February 11, 2008
12:00PM – 1:00PM
|
 |
|
Location:
|
 |
BALDWIN AUDITORIUM, LURIE BUILDING
|
 |
|
|
|
|
Selected Recent References for Robert Langenbach, PhD
Choi SH, Langenbach R, Bosetti F.Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury.FASEB J. 2007 Dec 27.
Lin JA, Watanabe J, Rozengurt N, Narasimha A, Martin MG, Wang J, Braun J, Langenbach R, Reddy ST. Atherogenic diet causes lethal ileo-ceco-colitis in cyclooxygenase-2 deficient mice. Prostaglandins Other Lipid Mediat. 2007 Nov;84(3-4):98-107. Epub 2007 Apr 25.
Narasimha A, Watanabe J, Lin JA, Hama S, Langenbach R, Navab M, Fogelman AM, Reddy ST. A novel anti-atherogenic role for COX-2--potential mechanism for the cardiovascular side effects of COX-2 inhibitors. Prostaglandins Other Lipid Mediat. 2007 Aug;84(1-2):24-33. Epub 2007 Mar 14.
Chun KS, Langenbach R. A proposed COX-2 and PGE(2) receptor interaction in UV-exposed mouse skin. Mol Carcinog. 2007 Aug;46(8):699-704. Review.
Chun KS, Akunda JK, Langenbach R. Cyclooxygenase-2 inhibits UVB-induced apoptosis in mouse skin by activating the prostaglandin E2 receptors, EP2 and EP4. Cancer Res. 2007 Mar 1;67(5):2015-21.
View more Publications by Robert Langenbach, PhD;
listed in the National Library of Medicine (PubMed) |
|
 |
|
|
|
|